We recently advised clients to avoid venture investment in gene sequencing, since the plummeting cost of the soon-mainstream procedure “will be a boon to patients, but a bane for personal...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)